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ElectronicpropertiesofDNAarebelievedtoplayacrucialroleinmanyphenomenainlivingorganisms,for
example the location of DNA lesions by base excision repair (BER) glycosylases and the regulation of
tumor-suppressor genes such as p53 by detection of oxidative damage. However, the reproducible
measurementandmodellingofchargemigrationthroughDNAmoleculesatthenanometerscaleremainsa
challenging and controversial subject even after more than a decade of intense efforts. Here we show, by
analysing 162 disease-related genes from a variety of medical databases with a total of almost 20,000
observed pathogenic mutations, a significant difference in the electronic properties of the population of
observed mutations comparedtothesetofall possiblemutations. Ourresultshaveimplications forthe role
of the electronic properties of DNA in cellular processes, and hint at the possibility of prediction, early
diagnosis and detection of mutation hotspots.
C
ells tend to accumulate over time genetic changes such as nucleotide substitutions, small insertions and
deletions, rearrangements of the genetic sequences and copy number changes
1. These changes in turn
affect protein-coding or regulatory components and lead to health issues such as cancer, immunodefi-
ciency, ageing-related diseases and other disorders. A cell responds to genetic damage by initiating a repair
process or programmed cell death
2. In recent years, a vast number of detailed databases have been assembled
in which rich information about the type, severity, frequency and diagnosis of many thousand of such observed
mutations has been stored
3–6. This abundance of data is based on the now standard availability of massively
parallel sequencing technologies
7. Harvesting these genomic databases for new cancer genes and hence potential
therapeutic targets has already demonstrated its usefulness
8 and several recent international cancer genome
projects continue the required large-scale analysis of genes in tumours
9.
The possible relevance of charge transport in DNA damage has recently also attracted considerable interest in
thebio-chemicalandbio-physicalliterature
10–13.Directmeasurementofchargetransportand/ortransferinDNA
remainsahighlycontroversialtopicduetotheverychallenginglevelofrequiredmanipulationatthenano-scale
14.
Ab-initio modelling of long DNA strands is similarly demanding of computational resources and so some of the
most promising computational approaches necessarily use much simplified models based on coarse-grained
DNA.
11 Here we compute and datamine the results of charge transport calculations based on two such effective
models for each possible mutation in 162 of the most important disease-associated genes from four large gene
databases. Themodelsare(i)thestandard one-dimensional chainofcoupled nucleicbaseswith onsiteionisation
potentials
11,15 as well as a novel 2-leg ladder model with diagonal couplings and explicit modelling of the sugar-
phosphate backbone
16.
Results
Point Mutations and Electronic Properties. We consider native genetic sequences and mutations of disease-
associatedgenesasretrievedfromtheOnlineMendelianInheritanceinMan(OMIM)
3ofNCBI,theHumanGene
MutationDatabase(HGMD)
4,theInternationalAgencyofResearchonCancer(IARC)
5aswellasRetinoblastoma
Genetics
6. We have selectedthese genes such that (i)those fromOMIMhave awell-known sequence with known
phenotype as well as at least 10 point mutations, (ii) all other selected cancer-related genes have also at least 10
point mutations and (iii) all non-cancer related genes from HGMD have at least 200 point mutations (cp.
Supplementary Table S1).
Many different types of mutation are possible in a genetic sequence including point mutations, deletion of
singlebasepairs(producingaframeshift),andlarge-scaledeletionorduplicationofmultiplebasepairs.Here,we
restrict our attention to point mutations as it allows us to directly compare the sequence before and after the
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SCIENTIFIC REPORTS | 2 : 272 | DOI: 10.1038/srep00272 1mutation. This leaves us with in total 19882 such mutations. We
study the magnitude of the change in charge transport (CT) for
pathogenic mutations when compared to all possible mutations
either locally, i.e. at the given hotspot site, or globally when ranked
accordingtomagnitudeofCTchange.Wefindthatthevastmajority
ofmutationsshowsgoodagreementwithahypothesiswheresmallest
change in electronic properties — as measured by a change in CT —
corresponds to a mutation that has appeared in one of the aforemen-
tioned databases of pathogenic genes.
A gene with N base pairs (bps) has a native nucleotide sequence
s1,s2,   ,sN ðÞ along the coding strand with si denoting one of the 4
possible nucleotide bases A,C,G,T. The gene has a total of 3N pos-
sible point mutations, which we denote as the set Mall, of which a
subset Mpa are known pathogenic mutations. A point mutation is
represented by the pair (k, s), where k is the position of the point
mutation in the genomic sequence and s is the mutant nucleotide
whichreplacesthenativenucleotide.Weshallwriteamutationfrom
a native base P to a mutant base Q as ‘‘Pq’’. We note that there are a
total of twelve possible point mutations for each nucleotide position
in a DNA sequence (from any one of four bases to any one of three
alternatives). Of these twelve, four are transitions, in which a purine
(A,G) base replaces a purine or a pyrimidine (C,T) replaces a pyr-
imidine, and eight are transversions in which purine is replaced by
pyrimidineorviceversa.Biologically,transitionsareingeneralmuch
more common than transversions
17. Indeed, the set of observed
pathogenic mutations for our 162 genes contains 10999 transitions
and8883transversions,whereasinthesetofallmutationstheirratio
is by definition 1 : 2. The observed pathogenic mutations are thus
already a biased selection from the set of possible mutations, favour-
ing transitions. However, this local onsite chemical shift is not suf-
ficient to fully explain our data as we will show later.
We compute and datamine the results of quantum mechanical
transport calculations based on two effective Hu ¨ckel models
18 for
each possible mutation in those 162 genes. The models are (i) the
standardone-dimensionalchainofcouplednucleicbaseswithonsite
ionisationpotentials
11,15aswellas(ii)anovel2-legladdermodelwith
diagonal couplings
16 and explicit modelling of the sugar-phosphate
backbone
19,22. Both models assume p–p orbital overlap in a well-
stacked double helix. The parameters are chosen to represent hole
transport. Using the transfer matrix method
20,21 we calculate the
spatial extent of (hole) wavefunctions of a given energy on a length
of DNA with a given genetic sequence. Wavefunction localisation is
directly related to conductance
20 and we therefore find it convenient
toreportourresultsintermsofconductance.Forthespecificmodels
discussed here (for the novel 2-leg model, its precursor versions) a
detailed study of the influence of the environment surrounding a
DNA strand on charge migration has been presented previously
22.
It was shown that while the conductance results exhibited some
quantitative differences, the main effect of the environment was an
overall reduction which depends on the exact choice of the envir-
onment. However, such an overall effect is not a primary concern
when CT changes are studied as in the present paper.
To determine the effect of a mutation, we consider sub-sequences
oflength Lbps; thereareL suchsequencesthat include agiven sitek.
For all L sequences we calculate quantummechanical charge trans-
mission coefficients T (in units of e2=B, averaged across a range of
incident energies, as detailed in Methods) for the native and mutant
sequences. We describe the effect of the mutation on the electronic
properties of the DNA strand near to the mutation site using the
mean square difference, C 5 ÆjTnative – Tmutantj
2æ, averaged across all
L sequences. Larger values of C therefore correspond to a greater
difference in electronic structure between the native and mutant
sequences.ThelengthLmustbelongenoughtoallowforsubstantial
delocalisation across multiple base pairs
22, but should remain below
the typical persistence length of,150 bps
23such thatany overlap or
crossing by packing, e.g. by wrapping around histone complexes in
chromatin, can be ignored. In this study we have considered lengths
of 20, 40, 60 bps. This requires, for each of the N sites in a gene, L
calculations for each sequence of length L and for each of 4 possible
bases at that site; which, for the more than 11 3 10
6 bases in our
dataset of 162 genes, is more than 5 3 10
9 quantum mechanical
transport calculations.
Local and global ranking. We first compare C of each observed
pathogenic mutation with the other two non-pathogenic ones at
the same position and determine a local ranking (LR) of CT
change. There are three possibilities of LR, namely low, medium
and high. Note that those hotspots with more than one pathogenic
mutations are excluded in the LR analysis. We have also sorted the
LRrankingforeachgeneaccordingtoprevalenceinFig.1(a1b).We
findthatforL520,40and60thelowCTchangecorrespondsto155
(95%), 148 (91%) and 140 (86%) of all 162 genes with pathogenic
mutations. This is significantly above the 33% line expected for
purely random DNA. Furthermore, the LR rankings cease their
high values for low CT change upon randomly reordering the
sequences. This indicates that it is indeed the fidelity of the
sequence which gives rise to the observed low CT change (see
examples of LR for the pathogenic mutations of p16 and CYP21A2
as well as the reordered p16 in Supplementary Fig. S3).
We can also consider a global ranking (GR) by sorting CT change
Cforallpossible3N mutationsofagenewithN bpsinordertogeta
ranking of every observed pathogenic mutation. By dividing each
ranking by 3N we compute the normalised GR c of the mutation,
with values between 0 and 1. Smaller values of c mean smaller CT
change. By analogy to the local ranking, we divide the cof the patho-
genic mutations into three groups as before, i.e. low (c , 33.3%),
medium(33.3%#c,66.7%),andhigh(c$66.7%)CTchange.The
results of the GR for the 162 genes are shown in the bottom row (c)
and(d)ofFig.1.AsfortheLRresults,weobservemanycvalueswith
low CT change (cp. Supplementary Figs. S3 and S4). Hence the LR
and GR results consistently show that observed pathogenic muta-
tions are generally biased towards smaller change in CT than the set
of all possible mutations (cp. Supplementary Fig. S5).
Distributionsofchangeinchargetransport.InFigure2weshowas
an example results for the distribution of C for the p16 DNA strand
forboth1Dand2-legmodels.Inpanels(a1b),itisclearthatthe111
observed pathogenic mutations of p16 have on average smaller
changes in the CT properties as compared to all possible 80220
mutations, for both the 1D and 2-leg models. We find that results
for the vast majority of the other 161 genes are quite similar. The
distributions of C values in Fig. 2(a1b) are approximately log-
normal. We therefore calculate, for each of the 162 genes in our
dataset, an average log C value for the distributions of all and
pathogenic mutations. Histograms of the distributions of these Ælog
Cæ values are shown in Fig. 2(c1d). It is once again clear that the
distributions for observed pathogenic mutations are shifted towards
lower C values in both the 1D and the 2-leg models.
We next define a global CT shift for a gene g as Lg 5 Ælog Cg,allæ –
ÆlogCg,paæ.PositivevaluesofLgindicatethattheobservedpathogenic
mutationsofgeneghavealoweraverageC.Foreachofour162genes
weobtainthedistributionofLgforthe1Dand2-legmodelsasshown
in Figs. 2(e1f). We can define, for the whole set of 162 genes, an
average global shift   L~
P
g Lg
.
162, weighting all genes equally; we
can also weight the results by the number of observed pathogenic
mutations for each gene jMpajg for a weighted average global shift
~ L~ 1 P
g Mpa jj g
P
g Mpa
       
gLg. These values are also indicated in
Figs. 2(e1f) and in both models there is a tendency towards lower
average   Lg for observed pathogenic mutations.
ThereforetheLRandGRmeasures,studied foravarietyofsystem
sizes and two different models for DNA, show that the pathogenic
mutationsfoundinthedatabasesaredistinguishedfromthesetofall
www.nature.com/scientificreports
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structure as measured by C. In Fig. 3, we present an average over all
12 LR and GR criteria and indicate the resulting agreement with the
CT hypothesis for each gene. As the figure shows, 161 of 162 genes
are above the no-signal (33%) line and hence show that for both 1D
and2-legmodelsandaveragedoverlengths20,40and60,asmallCT
change correlates with the existence and position of pathogenic
mutations.
Transitions and transversions. In our models we would expect
transitions to cause, in general, a smaller change in CT than trans-
versions, as the changein onsite energy andin transfer coefficients is
smaller for a transition than a transversion. However, as we will
demonstrate here, the increased proportion of transitions among
the observed pathogenic mutations is not sufficient to account for
the distributions seen in Fig. 2.
In Fig. 4(a1b) we show the distribution of C values for our entire
dataset of all . 34 3 10
6 possible mutations and 19882 known
pathogenic mutations, dividing the datasets into transitions and
transversions. For both models, the transitions are shifted to slightly
lower C values than the transversions. However, in the 2-leg model,
the distribution for observed pathogenic transitions appears co-
located with the distribution for all transitions, and likewise for
transversions.Inthe1Dmodel,bycontrast, theobserved pathogenic
transitions are visibly shifted to lower C values than the set of all
transitions, and the same is true for transversions.
In Fig.4(c1d) we represent the distributions of C values for each of
the twelve typesofpointmutation by pointsfor the meanvalues oflog
C and bars indicating the standard deviation of the distribution of log
C. In the2-leg model, thedistributions for observed pathogenic muta-
tions are essentially coincident with the distributions for all mutations
for each type Pq. The positive   L and ~ L shift results in the 2-leg model
are thus accounted for by the set of observed pathogenic mutations
being biased towards transitions. The 1D model displays a quite dif-
ferent behaviour; in each case the mean of the distribution for the
observed pathogenic mutations of any type Pq, lies from 7.5 to 20
standard errors below the mean for all possible mutations of type Pq.
Hence the probability that the observed pathogenic mutations are a
random subset of all mutations, with respect to their electronic prop-
erties in the 1D model, is comparable to the probability of drawing
twelve values more than 7.5 standard deviations below the mean from
a normal distribution, which is less than 10
–168. The observed differ-
ence between CT change between observed pathogenic and all pos-
sible mutations is thus statistically highly significant irrespective of
whether transitions or transversions are involved. In the 2D model,
by contrast, the means of the log C distributions for observed patho-
genic mutations can lie either above or below those for all mutations
for different types Pq, and the difference in the means — between 0.03
and 5.5 standard errors — is much smaller.
Let us also consider, for each gene g, simulation length L and each
mutation type Pq whether the subset shift l 5 Ælog Callæ – Ælog
Cpaæg,L,Pq is positive or negative. This gives us, for each model, 162
3 3 3 12 5 5832 data points, less 1029 cases where no calculation is
possibleasnopathogenicmutationsoftypePqareknownforgeneg.
These l data are presented in Fig. 5. In the 2-leg model there are
approximately equal numbers of negative and positive l values. This
Figure 1 | Sorted prevalence of the low, medium and high CT change among local (a1b) and global (c1d) rankings for pathogenic mutations in 162
genes using the 1D (a1c) and the 2-leg (b1d) models. Results are consistent for all three lengths L 5 20, 40, 60. The 1/3 value expected by chance is
shown as a dashed horizontal line. Low rankings are dramatically more prevalent locally and globally than chance would suggest.
www.nature.com/scientificreports
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mutationsofatypePq havethesamedistribution ofCvalesasforall
mutations of that type. In the 1D model, by contrast, such a null
hypothesis is decisively rejected: there is a preponderance of positive
l values by 2.2 : 1 (3326 positive to 1513 negative) and the binomial
probability of obtaining such a result at random would be approxi-
mately10
–153.Thetwoanalysesagreethatobservedpathogenicmuta-
tions display a significant bias towards smaller changes in electronic
properties in the 1D model.
Discussion
OurCTmodelsactasprobesofthestatisticsoftheDNAsequence.It
is possible that we are merely observing a correlation; i.e. that muta-
tions are more likely to occur in areas of the genome with certain
statistical properties, for reasons notcausally related to charge trans-
port, and these properties correlate with biased CT properties in our
1Dmodel.Suchacorrelationbetweenquantumtransportandmuta-
tion hotspots would in itself be a valuable and novel observation in
bioinformatics. There are known chemical biases in theoccurence of
mutations, such as the enhanced transition rate in C-G doublets
24,
the bias towards GC base pairs rather than AT pairs in biased gene
conversion
25,26and the tendency of holes tolocalise on GGand GGG
sequences and there cause oxidative damage
27. However, since our
observed bias is consistent across all twelve types of point mutation,
these known biases cannot fully account for our data.
There are also plausible causal connections between our data and
cellular genetic processes where the electronic properties of DNA may
be significant. One such process is gener e g u l a t i o n ,w h e r ec h a r g et r a n s -
Figure 2 | (a1b): Distribution of the change in charge transport C for pathogenic (orange bars) and all possible (cyan bars) mutations for the p16
(CDKN2A) gene with 26740 base pairs and 111 known pathogenic mutations. (c1d): Distribution of the average (logarithmic) change in charge
transport Ælog Cæ for all pathogenic (orange bars) and all possible (cyan bars) mutations for all 162 genes. (e1f): Distribution of the global shift L values
for all genes, showing a consistent tendency to positive values. The average   L (dashed) and weighted average ~ L (dash-dotted) values are indicated by
verticallinessimilarlytothe0line(dotted).Thegreybarsdenotetheerrorofmeanfor   L
  
.Theresultsforthe1Dand2-legmodelsaredisplayedinpanels
(a,c,e) and (b,d,f), respectively. All results shown are for L 5 40, data for L 5 20 and 60 are similar.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 272 | DOI: 10.1038/srep00272 4Figure 3 | Graphs of the average over all LR and GR criteria (cp.Fig. S5). The red data points and gene names correspond to an alphabetic ordering of
genes, whereas the blue points and labels are ordered according to the magnitude of the average. A larger average denotes a better agreement with our
hypothesis.Pointswhichliebelowthedashed33%lineshowgeneswhichonaveragefail.Results forHSD3B2(unsorted) andABCA4(sorted)havebeen
duplicated in both rows.
www.nature.com/scientificreports
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bound proteins, inducing protein conformational change and unbind-
ing
28. Similarly, it has been proposed that DNA repair glycosylases
containing redox-active [4Fe-4S] clusters
29 may localise to the site of
DNA lesions through a DNA-mediated charge transport mechanism
30.
The recognition of specific areas in the DNA sequence by DNA-bind-
ing proteinsgenerally may involveelectrostatic recognition of thetarget
DNA sequence
31. Furthermore, homologous recombination
32 —ap r o -
cess which is vital to the repair of double-strand breaks, a most serious
DNA lesion
33,34, and also to genetic recombination — relies on the
mutual recognition of homologous chromosomes before strand inva-
sion can occur. Homologous double-stranded DNA sequences are
capable of mutual recognition even in a protein-free environment
35,
presumably via electronic or electrostatic interactions
36–38.
All the above processes, especially those involving protein–DNA
or DNA–DNA recognition, would be less disrupted by a smaller
change in the electronic environment along the coding strand.
From this point of view, the observed mutations are biased to cause
lessdisruptiontogeneregulationandDNAdamagerepairinthecell.
This may seem counterintuitive at first. However, in order for a
mutation to appear in our dataset of pathogenic mutations, the cell
and the organism must develop viably for long enough for a mutant
phenotype to be observed. Mutations which cause large disruptions
toDNAregulationandrepairaremorelikelytobelethaltothecellat
an early stage and will thus be absent from disease databases.
Similarly, mutations which are more visible to DNA repair mechan-
isms are less likely to persist and to appear in databases.
Genetic repair and regulation mechanisms cannot know whether
the consequences of a mutation are beneficial, neutral or harmful.
We would therefore predict that neutral mutations should display
the same bias, towards smaller change in electronic structure, as we
observe in the pathogenic mutations. As a test of this prediction, we
haveconsideredthecaseoftheTP53gene,with20303basepairsand
for which there are known 2003 pathogenic mutations, 366 silent
mutations and 113 intronic mutations
5. We have simulated these
silent and intronic mutations using the 1D model. In Table 1 we
analyze the statistical properties for the resulting C distributions;
our results demonstrate that, for both transitions and transversions,
thesilentandintronicmutationsaresimilartothepathogenicmuta-
tions and significantly disimilar to the population of all possible
mutations, as predicted. For completeness, histograms of the distri-
bution of C values for these mutations are given in supplementary
material, see Fig. S7.
In conclusion, we have performed a large-scale data mining ana-
lysisofmutationdatabases andfindacorrelationbetween theoccur-
renceofmutationsandtheelectronicstructureunderlyingthecharge
transport calculations. This correlation is novel, but not necessarily
unexpected as we argue above. As ours is inherently a statistical
analysis, we have not been able to elucidate the causation behind
the correlation. Even so, the knowledge that the change in electronic
structure induced by mutations plays a role in fundamental bio-
logical and biochemical processes hints towards the possibility of
electronic prediction, early diagnosis and detection of mutation
hotspots.
Figure 4 |DistributionsofCforthe1D(a)and2-leg(b)modelsforallgenes,withmutationsdividedintotransitionsandtransversions.Thedistributions
are normalised by the size of the mutation dataset. Lines are guides to the eye only. The means (symbols) and standard deviations (error bars) of the
distributionsoflogCareshowninpanels(c)and(d)forthe1Dand2-legmodels.Estimatederrorsofthemeansaresmallerthanthesymbols.Distributions
areshownfortransition(Ti)andtransversion(Tv)mutations,andforthetwelvetypesofpointmutationindividually.Opensymbols(blue,cyan)arefor
the set of all mutations, filled symbols (orange, red) for the set of pathogenic mutations.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 272 | DOI: 10.1038/srep00272 6Figure 5 | Distributionofsubsetshiftslforthe2-leg(left)and1D(right)modelsoverall162genessplitintothe12possiblemutations(Ac,Ag,At,Ca,
…,Tc,Tg). Thecapitalletters onthe bottomaxesdenote the originalbase pairs,whereas thelowercase letters inthe topaxesshow themutant base.The
shortredtickmarksontherightaxesdistinguishdifferentoriginalbases.ThesystemsizesL520,40and60areshownintheleft,centreandrightcolumn
for each model. The orange shading corresponds to positive l and blue to negative. The white squares correspond to cases for which either no
corresponding pathogenic mutations are known (1029 cases) or for which the subset shift is inconclusive (3 cases for the 2-leg model).
www.nature.com/scientificreports
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Models of charge transport in DNA. The simplest model of coherent hole
transport in DNA is given by an effective one-dimensional Hu ¨ckel-Hamiltonian
for CT through nucleotide HOMO states
11, where each lattice point represents a
nucleotide base (A,T,C,G) of the chain for n 5 1, …, N. In this tight-binding
formalism, the on-site potentials n are given by the ionisation potentials G 5
7.75eV, C 5 8.87eV, A 5 8.24eV and T 5 9.14eV, at the nth site, cp. Fig. 6; the
hopping integrals tn,n11 are assumed to be nucleotide-independent with tn,n11 5
0.4eV
11. A model which is less coarse-grained is provided by the diagonal, 2-leg
ladder model shown in Fig. 6. Both strands of DNA and the backbone are
modelled explicitly and the different diagonal overlaps of the larger purines (A,G)
and the smaller pyrimidines (C,T) are taken into account by suitable interstrand
couplings
16,39. The intra-strand couplings are 0.35eV between identical bases and
0.17eV between different bases; the diagonal inter-strand couplings are 0.1eVf o r
purine-purine, 0.01eV for purine-pyrimidine and 0.001eV for pyrimidine-
pyrimidine. Perpendicular couplings to the backbone sites are 0.7eV, and
perpendicular hopping across the hydrogen bond in a base pair is reduced to
0.005eV. For previous discussions leading to these choices of parameters as well as
the influence of the environment on the charge migration properties of the
models, we refer the reader to the existing literature
11,12,22. We emphasise that we
have checked the robustness of our results; for example, the results for p53 do not
change qualitatively when using either tn,n11 5 0.1eVo r1 eV for the 1D model.
The 2-leg model
16 allows inter-strand coupling between the purine bases in
successive base pairs, in accordance with electronic structure calculations
39, and
should therefore be a better model for bulk charge transport along the DNA
double helix; the 1D model, by contrast, makes use of the site energies of only the
bases on the coding strand
15, and so is most representative of the electronic
environment along that strand. We also find that the 2-leg model recovers some of
the coding strand dependence of the 1D model upon decreasing the diagonal
hoppings. For 28 genes, we find that reducing just the diagonal hopping elements
by a factor of two leads to a much greater agreement with the 1D results similar to
Fig. 4(c).
Calculation of quantum transmission coefficients. The quantum transmission
coefficientT(E)foraDNAsequencewithlengthNbpsfordifferentinjectionenergyE
can be calculated for both models by using the transfer matrix method
21,40. Let us
define Tj,L(E) as the transmission coefficient for a part of a given DNA sequence
which starts at base pair position j and is L base pairs long. The position-dependent
averagedtransmissioncoefficientatthek–thbasepairfortransmissionlengthLbpsis
defined as
T
k ðÞ
L ~
1
L
X k
j~k{Lz1
1
E1{E0
ðE1
E0
Tj,L E ðÞ dE: ð1Þ
Here j ranges from k – L 1 1t ok such that each subsequence of length L contains
the kth base pair. E0 and E1 are the lower and upper bounds of the incident energy of
the carriers, e.g. for the 1D model used here, the values are 5.75 and 9.75eV,
respectively; for the 2-leg model the bounds are 7 and 11eV. We have used an energy
resolution of DE 5 0.005eV. Then we examine the difference between transmission
coefficients of the normal and mutated genomic sequence of a point mutation
15 and
hence denote by T
k,s ðÞ
j,L the transmission coefficient of the same segment of DNA as
T
k ðÞ
j,L but with the point mutation (k, s). C
k,s ðÞ
L is the averaged effect of the point
mutation (k, s) on CT properties for all subsequences of length L containing the
mutation,
C
k,s ðÞ
L ~
1
L
X k
j~k{Lz1
ðE1
E0
Tj,L E ðÞ {T
k,s ðÞ
j,L E ðÞ
     
     
2
E1{E0
dE: ð2Þ
Table 1 | Mean logarithm of CT change C for gene TP53 using the 1D model with L 5 20. Data are divided into transition and transver-
sions. We give standard errors of the mean (SEM) and standard deviations (s) for each distribution. From these we estimate the
probability of each distribution being a random sample from the set of all mutations, pall, or being a sample from a population similar
tothepathogenicmutations,ppa(cp.Fig.S7).Thereare224silenttransitionsand142silenttransversions;67intronictransitionsand46
intronic transversions. The pathogenic mutations and all possible mutations outnumber the silent and intronic populations by factors of
10–1000 and so it is the SEM for the smaller populations that is significant. It is clear that the mean CT change log10 C for the silent and
intronicpopulationsisfarmoresimilartothepathogenicpopulationsthantotheentirepopulationofallpossiblemutations.Thisistruefor
both transitions and transversions, although the p-value for the intronic transitions is not statistically significant (i.e. $ 0.05) which we
attribute to the small number of available intronic data.
log10 C SEM s pall ppa
All transitions 21.753 0.003 0.427 - -
Pathological
transitions
21.840 0.015 0.431 1.013
28 -
Silent transitions 21.868 0.029 0.440 6.623 10
25 0.391
Intron transitions 21.805 0.048 0.391 0.320 0.526
All transversions 21.605 0.002 0.422 - -
Pathological
transversions
21.710 0.012 0.4190 , 10
210 -
Silent transversions 21.691 0.036 0.432 0.016 0.610
Intron transversions 21.739 0.054 0.337 0.636
Figure 6 | Schematicmodels forchargetransport inDNA. Thenucleobases are given ascircles(red, denoting pairs)andellipses (blue,brownfor single
nucleotides). Electronic pathways are shown as solid lines of varying thickness to indicate variation in strength. Model (a) indicates the 1D model where
thesugar-phosphate backbone isignored. Inmodel(b),browncirclesdenote thesmallerpyrimidines, blueellipsesare thelargepurines andgreencircles
denotethesugar-phosphatebackbonesites.Notethatdiagonalhoppingbetweenpurinesisfavoured,andbetweenpyrimidinesdisfavoured,bythelarger
size of the purines.
www.nature.com/scientificreports
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